Metraipolis › archive › dc_b71bca5b998d

Renewed Response to Pembrolizumab After Salvage Radiotherapy for Oligoprogression in Advanced NSCLC: A Case Report — Europe PMC PMID:42459595

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42459595
DOI
10.1002/rcr2.70674
License (as archived)
solo-consultazione
Archived
2026-10-18T07:12:59.953Z
SHA-256 of the archived text
195fc2fec4904340162c3ec71a81056b058d8f8eec06330c4a328f1a9a9a034d
Stable URL of this page
https://metraipolis.com/documento/dc_b71bca5b998d

How to cite

Renewed Response to Pembrolizumab After Salvage Radiotherapy for Oligoprogression in Advanced NSCLC: A Case Report — Europe PMC PMID:42459595 — Europe PMC (en), https://europepmc.org/article/MED/42459595 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_b71bca5b998d (Metraipolis archive dc_b71bca5b998d, sha256 195fc2fec4904340162c3ec71a81056b058d8f8eec06330c4a328f1a9a9a034d)
BibTeX
@misc{dcb71bca5b998d,
  title = {Renewed Response to Pembrolizumab After Salvage Radiotherapy for Oligoprogression in Advanced NSCLC: A Case Report — Europe PMC PMID:42459595},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42459595},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_b71bca5b998d; sha256 195fc2fec4904340162c3ec71a81056b058d8f8eec06330c4a328f1a9a9a034d},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42459595. Agents can read the archived copy with the MCP tool read_document.